Experimental Stroke Drug Fails Late-Stage Trial
25622
The German biotechnology company Paion and its American partner, Forest Laboratories, announced the outcomes of the trial of its drug, desmoteplase.
704522
Unwanted phase 2 results might not scuttle a promising hepatitis C drug.
670072
A drug called t-PA can dissolve a brain-damaging blood clot, but only if itÂs used in time.
142646
A new antibody treatment for Alzheimer&#39;s has apparently halted its progression in a small human trial. The treatment lowers the amount of beta peptide in the brain, thought to be the cause of
86056
A study testing whether Celebrex or naproxen would reduce the risk of Alzheimer's disease was halted Monday after researchers noted an increase in heart attack and stroke among participants who were taking naproxen, an over-the-counter pain reliever on the market for nearly 30 years.
702482
The frustrating quest to develop a vaginal gel to prevent HIV infection was dealt a fresh blow on Monday as researchers announced that the first prototype to complete advanced clinical trials was ineffective.
619374
NEW YORK  - Discontinuing statin treatment after a stroke is associated with an increased risk of death or dependency after 90 days, according to a study in the medical journal Neurology.
648059
Isis Pharmaceuticals Inc. ISIS.O on  Wednesday said a late-stage clinical trial involving its  experimental cancer drug failed to meet its main target and  reported a wider third-quarter loss.
83518
Merck & Co and Schering-Plough Corp said a closely watched study involving its Vytorin cholesterol treatment failed to reach its main goal.
687657
A major trial looking at the best drugs to treat high blood pressure has been stopped early because the results were so good. Experts believe this could have major implications for the treatment of millions
608047
A blood-thinning drug not approved for  the U.S. market because of questions about liver damage appears  to be as effective as other common therapies for preventing  strokes and recurring blood clots, according to studies  published on Tuesday.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
377206
A study of the arthritis drug Celebrex casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.
203379
An international trial comparing blood-pressure lowering treatments has been stopped early due to the significantly better performance of one of the treatments in the trial.
451154
A drug approved last year as a last-ditch hope for some lung cancer patients who didn&#39;t find relief from other forms of therapy has come up short in a large clinical trial.
588084
Isis Pharmaceuticals Inc. said on  Thursday a trial of its experimental drug for Crohn's disease  did not work in a late stage clinical trial.
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch: